Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 2, 2012, Pages 179-185

  Borowoy, Alan M ^a   Pope, Janet E ^a   Silverman, Earl ^b   Fortin, Paul R ^c,d   Pineau, Christian ^e   Smith, C Douglas ^f   Arbillaga, Hector ^g   Gladman, Dafna ^c   Urowitz, Murray ^c   Zummer, Michel ^h   Hudson, Marie ⁱ   Tucker, Lori ^j   Peschken, Christine ^k  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITY OF MANITOBA   (Canada)

^k MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY;

ABORIGINE; ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; ORGANIC BRAIN SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RACE DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE FACTORS; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; CANADA; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC;

EID: 84866508808     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.03.011     Document Type: Article

References (33)

1. Hanly J.G., Urowitz M.B., Siannis F., Farewell V., Gordon C., Bae S.C., et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international inception cohort study. Arthritis Rheum 2008, 58(3):843-853.
2. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
3. Ainiala H., Loukkola J., Peltola J., Korpela M., Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001, 57(3):496-500.
4. Brey R.L., Holliday S.L., Saklad A.R., Navarrete M.G., Hermosillo-Romo D., Stallworth C.L., et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 2002, 58(8):1214-1220.
5. Jönsen A., Bengtsson A.A., Nived O., Ryberg B., Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: Increased morbidity but low mortality. Rheumatology (Oxford) 2002, 41(11):1308-1312.
6. Sanna G., Bertolaccini M.L., Cuadrado M.J., Laing H., Khamashta M.A., Mathieu A., et al. Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol 2003, 30(5):985-992.
7. Afeltra A., Garzia P., Mitterhofer A.P., Vadacca M., Galluzzo S., Del Porto F., et al. Neuropsychiatric lupus syndromes: Relationship with antiphospholipid antibodies. Neurology 2003, 61(1):108-110.
8. Hanly J.G., McCurdy G., Fougere L., Douglas J.A., Thompson K. Neuropsychiatric events in systemic lupus erythematosus: Attribution and clinical significance. J Rheumatol 2004, 31(11):2156-2162.
9. Mikdashi J., Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: Data from the Maryland lupus cohort. Rheumatology (Oxford) 2004, 43(12):1555-1560.
10. Zhou H.Q., Zhang F.C., Tian X.P., Leng X.M., Lu J.J., Zhao Y., et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: Analysis of 240 hospitalized patients. Lupus 2008, 17(2):93-99.
11. Bultink I.E., Turkstra F., Dijkmans B.A., Vokuyl A.E. High prevalence of unemployment in patients with systemic lupus erythematosus: Association with organ damage and health-related quality of life. J Rheumatol 2008, 35(6):1054-1057.
12. Hanly J.G., Su L., Farewell V., McCurdy G., Fougere L., Thompson K. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009, 36(7):1449-1459.
13. Briani C., Lucchetta M., Ghirardello A., Toffanin E., Zampieri S., Ruggero S., et al. Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort study. J Autoimmun 2009, 32(2):79-84.
14. González L.A., Pons-Estel G.J., Zhang J., Vilá L.M., Reveille J.D., Alarcón G.S., et al. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): A multi-ethnic lupus cohort. Lupus 2009, 18(9):822-830.
15. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25(11):1271-1277.
16. Asherson R.A., Mercey D., Phillips G., Sheehan N., Gharavi A.E., Harris E.N., et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: Association with antiphospholipid antibodies. Ann Rheum Dis 1987, 46(8):605-611.
17. Asherson R.A., Khamashta M.A., Gil A., Vazquez J.J., Chan O., Baguley E., et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989, 86(4):391-399.
18. Alarcón-Segovia D., Delezé M., Oria C.V., Sánchez-Guerrero J., Gómez-Pacheco L., Cabiedes J., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989, 68(6):353-365.
19. Peschken C.A., Katz S.J., Silverman E., Pope J.E., Fortin P.R., Pineau C., et al. The 1000 Canadian faces of lupus: Determinants of disease outcome in a large multiethnic cohort. J Rheumatol 2009, 36(6):1200-1208.
20. Karlson E.W., Daltroy L.H., Lew R.A., Wright E.A., Partridge A.J., Roberts W.N., et al. The independence and stability of socioeconomic predictors of morbidity and systemic lupus erythematosus. Arthritis Rheum 1995, 38(2):267-273.
21. Karlson E.W., Daltroy L.H., Lew R.A., Wright E.A., Partridge A.J., Fossel A.H., et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40(1):47-56.
22. Ward M.M., Pyun E., Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995, 38(2):274-283.
23. Liang M.H., Socher S.A., Larson M.G., Schur P.H. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989, 32(9):1107-1118.
24. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992, 35(6):630-640.
25. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the systemic lupus international Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39(3):363-369.
26. Bertoli A.M., Fernández M., Alarcón G.S., Vilá L.M., Reveille J.D. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): Factors predictive of self-reported work disability. Ann Rheum Dis 2007, 66(1):12-17.
27. Measurement of fatigue in systemic lupus erythematosus: A systematic review. Arthritis Rheum 2007, 57(8):1348-1357. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue.
28. Da Costa D., Dobkin P.L., Pinard L., Fortin P.R., Danoff D.S., Esdaile J.M., et al. The role of stress in functional disability among women with systemic lupus erythematosus: A prospective study. Arthritis Care Res 1999, 12(2):112-119.
29. Baker K., Pope J. Employment and work disability in systemic lupus erythematosus: A systematic review. Rheumatology (Oxford) 2009, 48(3):281-284.
30. Hanly J.G., Urowitz M.B., Su L., Bae S.C., Gordon C., Wallace D.J., et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010, 69(3):529-535.
31. González-Duarte A., Cantú-Brito C.G., Ruano-Calderón L., García-Ramos G. Clinical description of seizures in patients with systemic lupus erythematosus. Eur Neurol 2008, 59(6):320-323.
32. Karassa F.B., Afeltra A., Ambrozic A., Chang D.M., De Keyser F., Doria A., et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta-analysis. Arthritis Rheum 2006, 54(1):312-324.
33. Askanase A.D., Izmirly P.M., Katholi M., Mumtaz J., Buyon J.P. Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus. Lupus 2010, 19(3):300-306.